Collections and calls for papers

Despite the very promising results of systemic therapy for the majority of malignant diseases, there remain quite a number of malignancies that cannot be cured, i.e. the remission of the disease is transient...

With the increasing availability of large datasets and advanced computing power, AI holds the potential to transform how we approach cancer research and clinical practice. Its use in clinical oncology has al...

Cancer therapy using chimeric antigen receptor (CAR)-T-cells is one of the most exciting recent developments in cancer therapy. To date CAR-T-cells have been successfully used to treat persons with hematolog...

In this cross-journal collection, we welcome a wide range of articles on the role of N6-methyladenosine in cancer including primary research articles, method-based articles, reviews, and perspectives. N6-met...

In recent years, a great number of papers on nomograms in malignant diseases have been published in scientific journals and the internet. Nomograms are supposed to being used for prognoses and precision ther...

Precision medicine, replacing personalized therapy, is coming more and more into effect in a variety of modern medicine, especially in the diagnosis, prognosis and treatment of malignant diseases. Precision ...

A paradox in tumor immunity is the co-existing of growing tumors with circulating or tissue-infiltrating tumor-reactive T cells. The inability of tumor-reactive T cells in control of tumor growth has been at...